Some 30,000 Type 1 diabetes patients around the world are currently using the device, without the “skim” of Big Pharma adding to the cost.
https://www.nature.com/articles/d41586-023-02648-9
{{ Katarina Braune, an endocrinologist at Charité – Berlin University Medicine, estimates that around 30,000 people now use open-source technology for automated insulin delivery (AID). Some use Lewis and colleagues’ original OpenAPS system, which requires a minicomputer to control it, whereas others use either AndroidAPS (which evolved from Lewis’ system) or Loop, which are smartphone applications.
The movement has continued to mature. After years of relying on self-reported data, in the past year, two randomized controlled trials1,2 have shown the safety and effectiveness of open-source systems. And this January, the US Food and Drug Administration (FDA) granted regulatory clearance to an AID system based on an open-source algorithm for the first time. }}
intercst